MAPAI
LIVE

Serial Number

98749655

Owner

Komodo Health, Inc.

Attorney

Jordan A. LaVine

First Use Date

Sep 18, 2024

Filing Date

Sep 13, 2024

Add to watchlist:

No watchlists yet
View on USPTO

MAPAI Trademark

Serial Number: 98749655 • Registration: 8287161

MAPAI is a trademark filed by Komodo Health, Inc. on September 13, 2024. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Komodo Health, Inc. (26 trademarks)

680 Folsom Street, 5th Floor
San Francisco, CA 94107

Entity Type: 03

Trademark Details

Filing Date

September 13, 2024

Registration Date

June 2, 2026

First Use Anywhere

September 18, 2024

First Use in Commerce

September 18, 2024

Published for Opposition

April 22, 2025

Goods & Services

Business data collection and analysis services in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; business consulting and analysis services regarding information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; Providing business information in the field of the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapies; Business consulting services to businesses in the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapies

Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare viewing of a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs, all of the foregoing excluding psychedelic medicines and therapies; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (paas) featuring computer software platforms that allow the viewing of market access insights to the life sciences industry, provide business solutions that unify pharmaceutical sales, operations, and marketing data, and provide data intelligence that aids with effective targeting, messaging, and initiatives driving sales performance, all of the foregoing excluding psychedelic medicines and therapies; Design, development and implementation of computer software for the healthcare and life sciences industry, namely, the design and development of cloud-based and application-based software for monitoring, marketing, and delivering products in the healthcare and life sciences industry, all of the foregoing excluding psychedelic medicines and therapies; Consulting services in the fields of selection, implementation and use of computer hardware and software systems for others in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Business technology software consultation services in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Software development and product development consulting in the field of the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jun 2, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jun 2, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
May 11, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 11, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 18, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 18, 2026 AITU
USE AMENDMENT FILED
Nov 17, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Nov 17, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 17, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 22, 2025 NPUB
PUBLISHED FOR OPPOSITION
Apr 22, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 16, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 27, 2025 CNSA
ASSIGNED TO EXAMINER
Mar 13, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 24, 2025 NWOS
NEW APPLICATION ENTERED
Sep 13, 2024 NWAP